ArticleArXiv2025
Topological Machine Learning for Protein-Nucleic Acid Binding Affinity Changes Upon Mutation.
Article in ArXiv, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
3 authors.
Funding
Abstract
Understanding how protein mutations affect protein-nucleic acid binding is critical for unraveling disease mechanisms and advancing therapies. Current experimental approaches are laborious, and computational methods remain limited in accuracy. To address this challenge, we propose a novel topological machine learning model (TopoML) combining persistent Laplacian (from topological data analysis) with multi-perspective features: physicochemical properties, topological structures, and protein Transformer-derived sequence embeddings. This integrative framework captures robust representations of protein-nucleic acid binding interactions. To validate the proposed method, we employ two datasets, a protein-DNA dataset with 596 single-point amino acid mutations, and a protein-RNA dataset with 710 single-point amino acid mutations. We show that the proposed TopoML model outperforms state-of-the-art methods in predicting mutation-induced binding affinity changes for protein-DNA and protein-RNA complexes.
Identifiers
40492245PMC12148091What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.